Artiva Biotherapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Artiva Biotherapeutics's estimated annual revenue is currently $7.1M per year.
- Artiva Biotherapeutics's estimated revenue per employee is $134,528
- Artiva Biotherapeutics's total funding is $198M.
- Artiva Biotherapeutics has 53 Employees.
- Artiva Biotherapeutics grew their employee count by 77% last year.
Artiva Biotherapeutics Competitors & Alternatives
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is Artiva Biotherapeutics?
At Artiva, our mission is to deliver to cancer patients highly effective cellular immunotherapies that are also safe and immediately accessible. Towards this end, Artiva is advancing a pipeline of off-the-shelf, allogeneic NK cell therapies, including CAR-NK cell therapies, that leverage the company’s unique manufacturing and engineering capabilities. Artiva is headquartered in San Diego.keywords:N/A
Number of Employees
Employee Growth %
Artiva Biotherapeutics News
Artiva's platform supports large-scale production and cryopreservation of off-the-shelf allogeneic NK and CAR-NK therapeutics. About Artiva...
... the firm invested in Artiva Biotherapeutics, a private developer of ... adding that 5AM primarily gravitates toward therapeutics...
Skydio raised $170M; Artiva landed $120M; FogPharma secured $107M; Axonius picks up $100M Skydio: Skydio is a Redwood City, Ca.-based autonomous drone-maker. Skydio has raised $170 million in Series D funding at a post-money valuation of more than $1 billion led by earlier investor Andreessen H ...
San Diego-based biopharmaceuticals company Artiva Biotherapeutics has raised a big, $120M funding round, in its Series B funding, according to the company. The funding was led by Venrock Healthcare Capital Partners, and also included Acuta Capital Partners, Cormorant Asset Management, EcoR1 Capi ...
On February 26, 2021, Artiva Biotherapeutics, Inc. closed the transaction. The company raised funding led by by new investor Venrock Healthcare Capital Partners, a fund managed by Venrock. The transaction included participation from other new investors Acuta Capital Partners LLC, Cormorant Asset ...
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|